Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
1.460
-0.040 (-2.67%)
At close: Oct 14, 2024, 4:00 PM
1.470
+0.010 (0.68%)
After-hours: Oct 14, 2024, 7:13 PM EDT
Unity Biotechnology Market Cap
Unity Biotechnology has a market cap or net worth of $24.60 million as of October 14, 2024. Its market cap has decreased by -29.72% in one year.
Market Cap
24.60M
Enterprise Value
15.91M
1-Year Change
-29.72%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since May 3, 2018, Unity Biotechnology's market cap has decreased from $697.70M to $24.60M, a decrease of -96.47%. That is a compound annual growth rate of -40.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 25.30M | -10.28% |
| Dec 29, 2023 | 28.20M | -27.51% |
| Dec 30, 2022 | 38.90M | -53.86% |
| Dec 31, 2021 | 84.30M | -69.60% |
| Dec 31, 2020 | 277.30M | -16.27% |
| Dec 31, 2019 | 331.20M | -51.87% |
| Dec 31, 2018 | 688.20M | -1.36% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 25.84M |
| bioAffinity Technologies | 25.77M |
| Longeveron | 25.70M |
| IRIDEX | 25.62M |
| Inspira Technologies Oxy B.H.N. | 25.35M |
| ATI Physical Therapy | 25.26M |
| Lifeward | 25.18M |
| Pluri | 25.00M |